Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 23, 2025ChemistryOpenOpen Access

Synthesis of Pyrido2,3‐dAzolopyrimidinones: Design and Epidermal Growth Factor Receptor‐Targeted Molecular Docking Toward Novel Anticancer Leads

View Full Paper
Ask AI
Bookmark
Share

Authors

SGSobhi M. GomhaBFBasant FaragANAbdElAziz A. Nayl

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gomha et al. (2025) studied this question.

synapsesocial.com/papers/69403fa82d562116f290e7c2https://doi.org/10.1002/open.202500555
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synthesis of Pyrido[2,3‐d]Azolopyrimidinones: Design and Epidermal Growth Factor Receptor‐Targeted Molecular Docking Toward Novel Anticancer Leads2025
  2. 2Design, synthesis, and in silico studies of novel hybrid structures based on pyrimido-benzimidazole and 1,2,3-triazoles targeting oncogenic tyrosine kinases2026
  3. 3Synthesis of new pyrazolo[3,4-d]pyrimidines as potential mutant EGFR/HER2 and Bcl2 inhibitors: anticancer evaluation, DFT, molecular docking and ADME studies2026
  4. 4Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives2024 · 13 citations
  5. 5Design, Synthesis, and Molecular Docking Studies of Triazolylpyridine and Triazolylpyridinylbenzofuran Hybrids as Potential EGFR Inhibitors2025 · 1 citations